Basic Information
| RNALocate ID: | RLID:11003620 |
| RNA Symbol: | hsa-miR-101-5p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-101-5p |
| RNA ID: | miRBase:MIMAT0004513 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 24797360 |
| Tissue/Cell Line: | Cerebrospinal fluid |
| Method: | RNA sequencing |
| Description: | Differentially expressed miRNAs detected in the cerebrospinal fluid (CSF). Data are collected from Table 1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11003619 | Exosome | Plasma | 23663360 |
| RLID-D:11001469 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine | |
| RLID-D:11004078 | Microvesicle | Cell lines(GBM46|GBM8|HaCaT|K562|MCF-10A|MCF-7|MGG75)|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocytes |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-101-5p | Oral squamous cell carcinoma | MNDR-E-MI-02741 |
| MNDR | hsa-miR-101-5p | Medulloblastoma | MNDR-E-MI-02742 |
| MNDR | hsa-miR-101-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-02743 |
| MNDR | hsa-miR-101-5p | Spinocerebellar ataxia type 1 | MNDR-E-MI-02744 |
| MNDR | hsa-miR-101-5p | Lymphoma | MNDR-E-MI-02745 |
| MNDR | hsa-miR-101-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-02746 |
| MNDR | hsa-miR-101-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-02747 |
| MNDR | hsa-miR-101-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-02748 |
| MNDR | hsa-miR-101-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-02749 |
| MNDR | hsa-miR-101-5p | Her2-receptor positive breast cancer | MNDR-E-MI-02750 |
| MNDR | hsa-miR-101-5p | Dermatomyositis | MNDR-E-MI-02751 |
| MNDR | hsa-miR-101-5p | Prostate cancer | MNDR-E-MI-02752 |
| MNDR | hsa-miR-101-5p | B-cell chronic lymphocytic leukemia | MNDR-E-MI-02753 |
| MNDR | hsa-miR-101-5p | Gastric cancer | MNDR-E-MI-02754 |
| MNDR | hsa-miR-101-5p | Alzheimer disease | MNDR-E-MI-02755 |
| MNDR | hsa-miR-101-5p | Intracranial aneurysm | MNDR-E-MI-02756 |
| MNDR | hsa-miR-101-5p | Esophageal carcinoma | MNDR-E-MI-02757 |
| MNDR | hsa-miR-101-5p | Dysautonomia familial | MNDR-E-MI-02758 |
| MNDR | hsa-miR-101-5p | Duchenne muscular dystrophy | MNDR-E-MI-02759 |
| MNDR | hsa-miR-101-5p | Huntington disease | MNDR-E-MI-02760 |
| MNDR | hsa-miR-101-5p | Chorea | MNDR-E-MI-02761 |
| MNDR | hsa-miR-101-5p | Lung cancer | MNDR-E-MI-02762 |
| MNDR | hsa-miR-101-5p | Down syndrome | MNDR-E-MI-02763 |
| MNDR | hsa-miR-101-5p | Parkinson disease | MNDR-E-MI-02764 |
| MNDR | hsa-miR-101-5p | Breast cancer | MNDR-E-MI-02765 |
| MNDR | hsa-miR-101-5p | Thyroid cancer | MNDR-E-MI-02766 |
| MNDR | hsa-miR-101-5p | Pancreatic cancer | MNDR-E-MI-02767 |
| MNDR | hsa-miR-101-5p | Melanoma | MNDR-E-MI-02768 |
| MNDR | hsa-miR-101-5p | Rectum adenocarcinoma | MNDR-E-MI-02769 |
| MNDR | hsa-miR-101-5p | Nephroblastoma | MNDR-E-MI-02770 |
| MNDR | hsa-miR-101-5p | Colon cancer | MNDR-E-MI-02771 |
| MNDR | hsa-miR-101-5p | Colon adenocarcinoma | MNDR-E-MI-02772 |
| MNDR | hsa-miR-101-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-02773 |
| MNDR | hsa-miR-101-5p | Familial ovarian cancer | MNDR-E-MI-02774 |
| MNDR | hsa-miR-101-5p | Prostate adenocarcinoma | MNDR-E-MI-02775 |
| MNDR | hsa-miR-101-5p | Kidney cancer | MNDR-E-MI-02776 |
| MNDR | hsa-miR-101-5p | Carcinoma ductal breast | MNDR-E-MI-02777 |
| MNDR | hsa-miR-101-5p | Glioblastoma | MNDR-E-MI-02778 |
| MNDR | hsa-miR-101-5p | Astrocytoma | MNDR-E-MI-02779 |
| MNDR | hsa-miR-101-5p | malignant glioma | MNDR-E-MI-02780 |
| MNDR | hsa-miR-101-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-02781 |
| MNDR | hsa-miR-101-5p | Liposarcoma | MNDR-E-MI-02782 |
| MNDR | hsa-miR-101-5p | Myositis inclusion body | MNDR-E-MI-02783 |
| MNDR | hsa-miR-101-5p | Meningioma | MNDR-E-MI-02784 |
| MNDR | hsa-miR-101-5p | Liver cancer | MNDR-E-MI-02785 |
| MNDR | hsa-miR-101-5p | Gastric adenocarcinoma | MNDR-E-MI-02786 |
| MNDR | hsa-miR-101-5p | Cervical squamous cell carcinoma | MNDR-E-MI-02787 |
| MNDR | hsa-miR-101-5p | Lung squamous cell carcinoma | MNDR-E-MI-02788 |
| MNDR | hsa-miR-101-5p | Lung adenocarcinoma | MNDR-E-MI-02789 |
| MNDR | hsa-miR-101-5p | Pancreatic adenocarcinoma | MNDR-E-MI-02790 |
| MNDR | hsa-miR-101-5p | Carcinoma renal cell | MNDR-E-MI-02791 |
| MNDR | hsa-miR-101-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-02792 |
| MNDR | hsa-miR-101-5p | Renal clear cell carcinoma | MNDR-E-MI-02793 |
| MNDR | hsa-miR-101-5p | Lung small cell carcinoma | MNDR-E-MI-02794 |
| MNDR | hsa-miR-101-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-02795 |
| MNDR | hsa-miR-101-5p | Breast invasive carcinoma | MNDR-E-MI-02796 |
| MNDR | hsa-miR-101-5p | Hepatocellular carcinoma | MNDR-E-MI-02797 |
| MNDR | hsa-miR-101-5p | Familiar ovarian carcinoma | MNDR-E-MI-02798 |
| MNDR | hsa-miR-101-5p | Malignant pleural mesothelioma | MNDR-E-MI-02799 |
| MNDR | hsa-miR-101-5p | Neuroblastoma | MNDR-E-MI-02800 |
| MNDR | hsa-miR-101-5p | Neuromyelitis optica | MNDR-E-MI-02801 |
| MNDR | hsa-miR-101-5p | Colorectal cancer | MNDR-E-MI-02802 |
| MNDR | hsa-miR-101-5p | Nasopharynx carcinoma | MNDR-E-MI-02803 |
| MNDR | hsa-miR-101-5p | Ependymoma | MNDR-E-MI-02804 |
| MNDR | hsa-miR-101-5p | Nasopharyngeal cancer | MNDR-E-MI-02805 |
| MNDR | hsa-miR-101-5p | Stroke lacunar | MNDR-E-MI-02806 |
| MNDR | hsa-miR-101-5p | Breast cancer her3+ negative | MNDR-E-MI-02807 |
| MNDR | hsa-miR-101-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-02808 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ACKR3 | Homo sapiens | RR00034283 |
TOP